Drugs / MUMPS VIRUS VACCINE LIVE
MUMPS VIRUS VACCINE LIVE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06208683 | Nov 2023 → Feb 2024 | influenza, mumps infectious disease | Sinovac Biotech Co., Ltd | Unknown | No outcome recorded |
| Phase 4 | NCT04364399 | Nov 2020 | mumps infectious disease | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MUMPS VIRUS VACCINE LIVE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109201 ↗ |
| Known as | Mumps vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04364399 ↗ |
| Known as | Mumps vaccine (live attenuated) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109201 ↗ |
| Known as | Mumps vaccine, Live | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06208683 ↗ |
| Known as | Mumps virus live antigen, a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109201 ↗ |
| Known as | Mumpsvax | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109201 ↗ |
| Known as | Virus mumps (jeryl lynn strain) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109201 ↗ |
| Modality | Vaccine | “One dose of mumps vaccine: 0.5 ml per dose, mumps live virus not less than 3.7 lg CCID50” NCT04364399 ↗ |